Seasoned consumer health operator to lead IM HealthScience in 2017

BOCA RATON, Fla. – IM HealthScience announced Thursday the planned retirement of Ellen Geisel, president, who will be leaving the company in March 2017. Dave Swenson, VP marketing and operations, will assume the role of president upon Geisel's retirement.

 

"Dave has played a critical role in the successful commercialization of our first product, IBgard," Geisel said. "I am confident that under Dave's leadership the company will continue to grow rapidly through the continued strong growth of IBgard and the launch of additional, innovative medical food products in the pipeline. You could not find a better, more experienced commercial executive to assume my responsibilities." 

 

Swenson joined IM HealthScience in August 2015. Prior to joining the company, he was managing director of DOS & Associates. At DOS, his practice focused primarily on start-ups and in bringing healthcare innovations to the consumer marketplace. Prior to this role, he was general manager at Alaven Consumer Healthcare where he formed a consumer healthcare division with specialty products in personal hygiene and gastroenterology.  

Swenson spent 16 years at Wyeth Consumer HealthCare in commercial positions where he worked on more than 30 healthcare brands, including Advil and Centrum Vitamins. 

 

“I am grateful to Ellen for her mentorship,” Swenson said. “I also am grateful to her for being our leader in successfully launching the company and our lead product, IBgard, and her legacy will be strong and deep. I am both humbled and honored to be chosen for this position," he added. "I look forward to working with my IMH colleagues to commercialize our exciting pipeline of innovative medical foods for the management of various gastrointestinal disorders."